| Ytd | -9.46% | |
| 1y | 15.72% |
| Open | 34.05 | Prev Close | 33.86 | Low | 33.69 | High | 34.20 | Mkt Cap | 1.37B |
| Vol | 38.00K | Avg Vol | 365.39K | EPS | 2.93 | P/E | 11.56 | Forward P/E | 13.83 |
| Beta | 0.46 | Short Ratio | 3.73 | Inst. Own | 100.86% | Dividend | 0.48 | Div Yield | 1.44 |
| Ex Div Date | 06-03 | Earning | 05-06 | 50-d Avg | 32.82 | 200-d Avg | 42.71 | 1yr Est | 45.60 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Investors interested in stocks from the Medical - Products sector have probably already heard of Phi
Investors need to pay close attention to PAHC stock based on the movements in the options market lat
The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Ph
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001069899/000110465926078323/tm2619111d1_8k.htm
Investors interested in stocks from the Medical - Products sector have probably already heard of Phi
Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected
This animal health provider, serving global livestock markets, reported a notable insider buy in its
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro A
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Investors need to pay close attention to PAHC stock based on the movements in the options market lat
On May 28, 2026, Phibro Animal Health Corp (PAHC) shares fell 3.1% today, closing at $31.83. The sto
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it w
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro A
Citigroup analyst Daniel Grosslight maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral a
Phibro Animal Health Corporation (PAHC) Presents at Bank of America Global Healthcare Conference 202
Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Review Phibro's (PAHC) international revenue performance and how it affects the predictions of finan
Phibro Animal Health Corporation (PAHC) Q3 2026 Earnings Call Transcript
FISCAL YEAR 2026 FINANCIAL GUIDANCEOur updated fiscal year 2026 financial guidance is as shown below
The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27,
Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 GAAP EPS guidance from $1.83-$2.08 to $2.08-$2.32 v
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.64-$2.81 to $2.93-$3.10 vs
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.87 per share which beat the ana
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quart
Monday saw 825 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.
During Wednesday's morning trading, 251 companies set new 52-week highs.
Before 10 a.m. ET Monday, 296 stocks made new 52-week highs.
Stocks That Hit 52-Week Lows On Monday